Recent years, obesity is a growing health problem also in patients with chronic renal failure and end it’s end stage. This situation has a negative impact both on the extension of the waiting period for transplantation, and the survival rate of the transplanted organ and the recipient. Weight loss through lifestyle modification before transplantation is ambiguous. Its well known fact of rapid body mass gain after transplantation, and finnaly the results of transplantation are not better than those of patients who have not reduced body weight. The paper presents preliminary experience associated with bariatric operations of three chronic dialysed patients with morbid obesity BMI> 35 kg/m2, all patients had been treated by Roux-en-Y gastric by-pass (RYGB). All operated patients were classified as potential recipients were listed by Poltransplant. One of them three months after RYGB surgery underwent without complications a renal transplantation. Preliminary experiences based on operating these three caese confirmed the complete safety of this type of approach in patients with end-stage chronic kidney disease (CKD).
The aim of the study: The study aimed to determine whether persons suffering from obesity may be characterised by specific personality traits which promote the development of excess body weight. Additionally, the aim involved finding whether persons suffering from morbid obesity differed from healthy individuals and somatic patients as regards selected personality traits. Material and methods: The study enrolled 34 patients with the diagnosis of morbid obesity in the process of qualification for surgical treatment of obesity. The patients’ BMI ranged from 35 to 54 kg/m2. Study participants completed NEO-FFI personality inventory (Costa, McCare; 1998) and the authors’ questionnaire designed to collect demographic data and anthropometric measurements. R esults: The study showed that patients with morbid obesity significantly differed from healthy individuals and somatic patients as regards the analysed measurements of the Big Five. C onclusions: The traits which were significantly distinctive in morbidly obese patients included lowered conscientiousness and increased neuroticism. The results indicate that the above pattern of personality traits may promote the development of excessive body weight.
Introduction; p to 300 million people have the body mass index (BMI) greater than 30 kg/m2. Obesity is the cause of many serious diseases, such as type 2 diabetes, hypertension, and non-alcoholic fatty liver disease (NAFLD). Bariatric surgery is the only effective method of achieving weight loss in patients with morbid obesity. Objectives: The aim of the study was to assess the impact of bariatric surgery on non-alcoholic fatty liver disease in patients operated on due to morbid obesity. Material and Methods: We included 20 patients who were qualified for bariatric procedures based on BMI > 40 kg/ m2 or BMI > 35kg/m2 with the presence of comorbidities. The average body weight in the group was 143.85kg, with an average BMI of 49.16kg/m2. Before the procedure, we evaluated the severity of non-alcoholic fatty liver disease in each patient using the Sheriff-Saadeh ultrasound scale. We also evaluated the levels of liver enzymes. Follow-up evaluation was performed twelve months after surgery. Results: Twelve months after surgery, the average weight was 102.34 kg. The mean %WL was 33.01%, %EWL was 58.8%, and %EBMIL was 61.37%. All patients showed remission of fatty liver disease. Liver damage, evaluated with ultrasound imaging, decreased from an average of 1.85 on the Sheriff-Saadeh scale, before surgery, to 0.15 twelve months after surgery (p < 0.001). As regards liver enzymes, the level of alanine aminotransferase decreased from 64.5 (U/l) to 27.95 (U/l) (p < 0.001), and the level of aspartate aminotransferase decreased from 54.4 (U/l) to 27.2 (U/l). Conclusions: Bariatric procedures not only lead to a significant and lasting weight loss, but they also contribute to the reduction of fatty liver disease and improve liver function.
The aim of the studywas an assesment the impact of weight loss in patients undergoing gastricby‑pass surgery on an aggressive behavior affecting the satisfaction with the connubial or cohabitation relationship Material and methods. The study included a total number of 100 people (50 people with morbid obesity underwent gastric-bypass surgery and their male or female partners). The study was conducted by using two questionnaires: the Psychological Inventory of Aggression Syndrome-1 authorship by Z.B. Gaś as well as Extinguishes and the Chosen Marriage Questionnaire-2 developed by M. Plop and J. Rostowski Results. The analysis of the results showed the influence of the weight loss on the aggressive behaviour at the examined group. Important differences were shown in the first phase of the examination among the examined group and the control group on scales: emotional self-aggression, the hostility towards surroundings and directed outside aggression. Regression analysis showed a statistical relationship between outward aggression and disappointment, 0.346 p<0.01, intimacy 0.943 p<0.01, and the result of general satisfaction with the relationship 0.832 p<0.05.While self-realization is negatively correlated with a displaced aggression -0.342 p<0.01 and the intermediate one -0.225 p<0.01. Hostility towards the environment correlates positively with intimacy 0.326 p<0.01. Indirect aggression correlates negatively with a disappointment -0.324 for p <0.05. Important differences were shown in the second stage of the examination among groups examined on the scale inspection of the aggressive behaviour. Substantial results weren’t demonstrated on scales: emotional self-aggression, hostility towards the environment and directed outside aggression In the regression analysis we received a statistically significant result: controlling an aggressive behavior correlates negatively with disappointment -0, 355 p <0,01. However, no statistically significant results were received from the partners of obese people. Conclusions. Weight loss after gastric-by-pass surgery has the significant impact on the rarer occurrence of an aggressive behavior, which improving the quality of the connubial or cohabitation relationship.
Aim of the study: The aim of this study was to evaluate the influence of laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric by-pass on risk factors of cardiovascular diseases. Material and methods: We analyzed prospectively collected data of patients operated for morbid obesity who were qualified for laparoscopic sleeve gastrectomy (LSG) or laparoscopic Roux-en-Y gastric by-pass (LRYGB). Risk factors for wyłączecardiovascular diseases were assessed with the SCORE scale and both full and hard Framingham cardiovascular risk scores (FCRs). The data were collected on admission and one year after the procedures. We enrolled 264 patients (119 females, 116 males, 40.2±9.9 years old), of whom 117 underwent LRYGB and 118 LSG, respectively. Results: Preoperatively, 12% of patients were in the high-risk category of the SCORE scale, 65% were in the moderate risk category, and 24% were in the low-risk category. The median score of the SCORE scale was 1 (1-2). Lipid-based full FCR was 34.5% (24%-68%) and the hard FCR was 17.5% (10%-52%), while the respective BMI-based FCRs were 59% (31%-84%) and 37% (15%-67%). One year after the procedures, the mean %EBMIL (62.88%±20.02%) and %EWL (53.18%±15.87) were comparable between both procedures. Hypertension treatment was not necessary in 33 patients after LSG and in 55 after LRYGB. Diabetes mellitus remitted in 9 and 29 patients, respectively. Both procedures significantly reduced high and moderate risk prevalence in the SCORE scale in favor of the low risk category. Surgical interventions resulted in significant reductions of FCRs 1 year after surgery ( p<0.001). Conclusions: Both LSG and LRYGB lead to a significant and comparable body mass reduction. Both procedures significantly decrease of the risk of cardiovascular diseases, based on SCORE and Framingham scales.
INTRODUCTION: Morbid obesity and its accompanying multimorbidity constitute a significant public health problem. AIM: The aim of the study is to evaluate the effect of endoscopic implantation of an intragastric balloon on the ailments and associated diseases in people with obesity. MATERIAL AND METHODS: The study included 75 people treated by intragastric balloon implantation. The sample selection was purposeful. The patients were qualified for balloon implantation, according to recognized indications for the endoscopic treatment of obesity. All the analyses were performed using Statistica 12. Results for which p < 0.05 were considered as statistically significant. RESULTS: Positive effects of the treatment of obesity by intragastric balloon implantation in relation to comorbidities were observed in 54 patients (62%), 30 people (40%) achieved minimal health improvement, the regression of one serious disease and alleviation others in 24 patients (32%). 21 patients (28%) had no improvement in their health status. None of the patients reported the resolution of all major diseases, but there was also no deterioration in the health of any patient. There was a statistically significant reduction in the incidence of hypertension, type 2 diabetes, spinal pain, osteoarthritis, sleep apnoea, menstrual disorders, impotence and dyspnoea during IGB treatment. CONCLUSIONS: Treatment by endoscopic implantation of an intragastric balloon alleviates the course or reduces the incidence of concomitant diseases in persons with morbid obesity.
PL
WSTĘP: Otyłość olbrzymia i towarzysząca jej wielochorobowość stanowią poważny problem zdrowia publicznego. CEL: Celem pracy jest ocena wpływu endoskopowej implantacji balonu wewnątrzżołądkowego na dolegliwości i choroby towarzyszące u osób z otyłością. MATERIAŁ I METODY: Badaniem objęto 75 osób leczonych metodą implantacji balonu wewnątrzżołądkowego. Pacjenci zostali zakwalifikowani do implantacji balonu, zgodnie z uznanymi wskazaniami do endoskopowego leczenia otyłości. Wszystkie analizy przeprowadzono za pomocą Statistica 12. Za poziom istotności statystycznej przyjęto p < 0,05. WYNIKI: Pozytywne efekty leczenia otyłości metodą implantacji balonu wewnątrzżołądkowego w odniesieniu do współistniejących chorób zaobserwowano u 54 pacjentów (62%), 30 osób (40%) osiągnęło minimalną poprawę stanu zdrowia, u 24 pacjentów (32%) ustąpiło co najmniej jedno zasadnicze schorzenie. 21 pacjentów (28%) nie wskazywało poprawy stanu zdrowia. Żaden z pacjentów nie zgłosił ustąpienia wszystkich głównych chorób, ale również nie nastąpiło pogorszenie stanu zdrowia. Podczas leczenia IGB stwierdzono statystycznie istotne zmniejszenie występowania nadciśnienia, cukrzycy typu 2, bólu kręgosłupa, choroby zwyrodnieniowej stawów, bezdechu sennego, zaburzeń miesiączkowania, impotencji i duszności. WNIOSKI: Leczenie otyłości metodą endoskopowej implantacji balonu wewnątrzżołądkowgo zmniejsza częstość współistniejących chorób u osób z otyłością olbrzymią.
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.